Phase II Study to Evaluate Efficacy and Safety of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer. This Study is an Extension Study for Japanese Registration Only.
Phase II Study to Evaluate Efficacy and Safety of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer. This Study is an Extension Study for Japanese Registration Only.
The purpose of this clinical research study is to learn if BMS-181339 can shrink or slow the growth of the cancer in patients with advanced or recurrent esophageal cancer. The safety of this treatment will also be studied.
Inclusion Criteria:
Exclusion Criteria:
Kashiwa-Shi, Chiba 277-0882, Japan
Sagamihara-Shi, Kanagawa 228-8520, Japan
Suita-Shi, Osaka, Japan
Takatsuki-Shi, Osaka 569-8686, Japan
Sunto-Gun, Shizuoka 411-8777, Japan
Chuo-Ku, Tokyo 104-0045, Japan
Toshima-Ku, Tokyo 170-8455, Japan